DOI: 10.1182/blood.v96.2.384.013k07_384_392. Stimulation of γδ T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma

Stimulation of γδ T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma

10.1182/blood.v96.2.384.013k07_384_392

Crossref journal-article

American Society of Hematology

Blood (234)

Abstract

Bisphosphonates are well-known inhibitors of osteoclastic bone resorption, but recent clinical reports support the possibility of direct or indirect antitumor effects by these compounds. Because bisphosphonates share structural homologies with recently identified γδ T-cell ligands, we examined the stimulatory capacity of bisphosphonates to γδ T cells and determined whether γδ T-cell stimulation by bisphosphonates could be exploited to generate antiplasma cell activity in multiple myeloma (MM). All tested aminobisphosphonates (alendronate, ibandronate, and pamidronate) induced significant expansion of γδ T cells (Vγ9Vδ2 subset) in peripheral blood mononuclear cell cultures of healthy donors at clinically relevant concentrations (half-maximal activity, 0.9-4 μmol/L). The proliferative response of γδ T cells to aminobisphosphonates was IL-2 dependent, whereas activation of γδ T cells (up-regulation of CD25 and CD69) occurred in the absence of exogenous cytokines. Pamidronate-activated γδ T cells produced cytokines (ie, interferon [IFN]-γ) and exhibited specific cytotoxicity against lymphoma (Daudi) and myeloma cell lines (RPMI 8226, U266). Pamidronate-treated bone marrow (BM) cultures of 24 patients with MM showed significantly reduced plasma cell survival compared with untreated cultures, especially in cultures in which activation of BM-γδ T cells was evident (14 of 24 patients with MM). γδ T-cell depletion from BM cultures completely abrogated the cytoreductive effect on myeloma cells in 2 of 3 tested patients with MM. These results show that aminobisphosphonates stimulating γδ T cells have pronounced effects on the immune system, which might contribute to the antitumor effects of these drugs.

Bibliography

Kunzmann, V., Bauer, E., Feurle, J., Tony, F. W., Hans-Peter, & Wilhelm, M. (2000). Stimulation of Î³Î´ T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood, 96(2), 384â392.

Authors 5

Volker Kunzmann (first)
Eva Bauer (additional)
Juliane Feurle (additional)
Florian Weißinger, Hans-Peter Tony (additional)
Martin Wilhelm (additional)

References 44 Referenced 143

10.1056/NEJM199602223340802 / N Engl J Med. / Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma: Myeloma Aredia Study Group. by Berenson (1996)
10.1046/j.1365-2141.1998.00567.x / Br J Haematol. / A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma: MRC Working Party on Leukaemia in Adults. by McCloskey (1998)
10.1172/JCI118722 / J Clin Invest. / Bisphosphonates: mechanisms of action. by Rodan (1996)
10.1200/JCO.1998.16.2.593 / J Clin Oncol. / Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events: Myeloma Aredia Study Group. by Berenson (1998)
10.1046/j.1365-2141.1998.00976.x / Br J Haematol. / Antimyeloma activity of pamidronate in vivo. by Dhodapkar (1998)
{'key': '2019112005393004600_B6', 'first-page': '3551', 'article-title': 'Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.', 'volume': '55', 'author': 'Sasaki', 'year': '1995', 'journal-title': 'Cancer Res.'} / Cancer Res. / Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. by Sasaki (1995)
10.1182/blood.V82.6.1787.1787 / Blood. / Rapid generation of antiplasma cell activity in the bone marrow of myeloma patients by CD3-activated T cells. by Massaia (1993)
{'key': '2019112005393004600_B8', 'first-page': '72', 'article-title': 'Tumor-directed cytotoxicity in multiple myeloma—the basis for an experimental treatment approach with interleukin 2.', 'volume': '2', 'author': 'Peest', 'year': '1995', 'journal-title': 'Stem Cells.'} / Stem Cells. / Tumor-directed cytotoxicity in multiple myeloma—the basis for an experimental treatment approach with interleukin 2. by Peest (1995)
10.1016/S0140-6736(95)90757-2 / Lancet. / Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor. by Kwak (1995)
10.1146/annurev.iy.11.040193.003225 / Annu Rev Immunol. / Gamma/delta cells. by Haas (1993)
10.1126/science.1978758 / Science. / Recognition by human Vγ9/Vδ2 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells. by Fisch (1990)
10.4049/jimmunol.154.3.998 / J Immunol. / Vγ2Vδ2 TCR-dependent recognition of nonpeptide antigens and Daudi cells analyzed by TCR gene transfer. by Bukowski (1995)
10.1038/375155a0 / Nature. / Natural and synthetic nonpeptide antigens recognized by human γ/δ T cells. by Tanaka (1995)
10.1126/science.8146660 / Science. / Stimulation of human γδ T cells by nonpeptidic mycobacterial ligands. by Constant (1994)
10.1002/eji.1830250737 / Eur J Immunol. / Human Vγ9-Vδ2 cells are stimulated in a cross-reactive fashion by a variety of phosphorylated metabolites. by Burk (1995)
10.1073/pnas.91.17.8175 / Proc Natl Acad Sci U S A. / Nonpeptide ligands for human γδ T cells. by Tanaka (1994)
10.1016/S0167-5699(97)80010-2 / Immunol Today. / Sentinel function of broadly reactive human γδ T cells. by De Libero (1997)
10.1056/NEJM199903043400914 / N Engl J Med. / γ/δ T-cell stimulation by pamidronate [letter]. by Kunzmann (1999)
10.1038/375155a0 / Nature. / Natural and synthetic nonpeptide antigens recognized by human γδ T cells. by Tanaka (1995)
10.1093/jnci/84.10.788 / J Natl Cancer Inst. / Pharmacokinetics of pamidronate in patients with bone metastases. by Leyvraz (1992)
10.1172/JCI115539 / J Clin Invest. / Bisphosphonate action: alendronate localization in rat bone and effects on osteoclast ultrastructure. by Sato (1991)
10.1002/eji.1830270422 / Eur J Immunol. / Comparative analysis of αβ and γδ T cell activation by Mycobacterium tuberculosis and isopentenyl pyrophosphate. by Wesch (1997)
10.4049/jimmunol.161.1.286 / J Immunol. / Crucial role of TCR γ chain junctional region in prenyl pyrophosphate antigen recognition by γδ T cells. by Bukowski (1998)
10.1359/jbmr.1998.13.4.581 / J Bone Miner Res. / Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. by Luckman (1998)
10.1073/pnas.96.1.133 / Proc Natl Acad Sci U S A. / Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. by Fisher (1999)
10.1359/jbmr.1997.12.9.1358 / J Bone Miner Res. / Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5′-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro. by Frith (1997)
10.1016/8756-3282(95)00448-3 / Bone. / Interleukin-6 and tumor necrosis factor α levels after bisphosphonates treatment in vitro and in patients with malignancy. by Sauty (1996)
10.1007/s002239900353 / Calcif Tissue Int. / An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates. by Thiebaud (1997)
{'key': '2019112005393004600_B29', 'first-page': '446a', 'article-title': 'Effects of the bisphosphonates pamidronate, clodronate and ibandronate on CD69, an early T-lymphocyte activation marker [abstract].', 'volume': '17', 'author': 'Pecherstorfer', 'year': '1998', 'journal-title': 'Proc ASCO.'} / Proc ASCO. / Effects of the bisphosphonates pamidronate, clodronate and ibandronate on CD69, an early T-lymphocyte activation marker [abstract]. by Pecherstorfer (1998)
10.1084/jem.185.1.91 / J Exp Med. / Functional inactivation in the whole population of human Vγ9/Vδ2 T lymphocytes induced by a nonpeptidic antagonist. by Burk (1997)
10.1084/jem.169.5.1557 / J Exp Med. / Cytotoxic T lymphocytes specific for self-tumor immunoglobulin express T cell receptor delta chain. by Wright (1989)
{'key': '2019112005393004600_B32', 'first-page': '129', 'article-title': 'Human CD3 γδ+ activated lymphocytes exhibit killer activity in vitro against autologous leukemic cells.', 'volume': '31', 'author': 'Bensussan', 'year': '1989', 'journal-title': 'Nouv Rev Fr Hematol.'} / Nouv Rev Fr Hematol. / Human CD3 γδ+ activated lymphocytes exhibit killer activity in vitro against autologous leukemic cells. by Bensussan (1989)
{'key': '2019112005393004600_B33', 'first-page': '863', 'article-title': 'Potential antileukemic effect of γδ T cells in acute lymphoblastic leukemia.', 'volume': '9', 'author': 'Duval', 'year': '1995', 'journal-title': 'Leukemia.'} / Leukemia. / Potential antileukemic effect of γδ T cells in acute lymphoblastic leukemia. by Duval (1995)
10.1089/scd.1.1996.5.503 / J Hematother. / Increased frequency of TCR γδ+ T cells in disease-free survivors following T cell-depleted, partially mismatched, related donor bone marrow transplantation for leukemia. by Lamb (1996)
10.1111/j.1365-2141.1995.tb05594.x / Br J Haematol. / CD3-induced T-cell activation in the bone marrow of myeloma patients: major role of CD4+ cells. by Bianchi (1995)
10.1056/NEJM199110103251506 / N Engl J Med. / A subcutaneous delta-positive T-cell lymphoma that produces interferon gamma. by Burg (1991)
10.1002/eji.1830211215 / Eur J Immunol. / Functionally distinct subsets of human γ/δ T cells. by Morita (1991)
10.1182/blood.V81.11.3076.3076 / Blood. / γ-Interferon in multiple myeloma: inhibition of interleukin-6 (IL-6)-dependent myeloma cell growth and downregulation of IL-6-receptor expression in vitro. by Portier (1993)
10.1182/blood.V92.8.2914.420k14_2914_2923 / Blood. / Fas/APO-1 (CD95)-mediated apoptosis is activated by interferon-γ and interferon-α in interleukin-6 (IL-6)-dependent and IL-6-independent multiple myeloma cell lines. by Spets (1998)
10.1046/j.1365-2141.1997.2713086.x / Br J Haematol. / Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity. by Shipman (1997)
10.1038/sj.leu.2400892 / Leukemia. / In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates. by Aparicio (1998)
{'key': '2019112005393004600_B42', 'first-page': '5294', 'article-title': 'The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway.', 'volume': '58', 'author': 'Shipman', 'year': '1998', 'journal-title': 'Cancer Res.'} / Cancer Res. / The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway. by Shipman (1998)
10.1080/030097498441155 / Scand J Rheumatol. / Bisphosphonates inhibit IL-6 production by human osteoblast-like cells. by Giuliani (1998)
{'key': '2019112005393004600_B44', 'first-page': '105a', 'article-title': 'Pamidronate reduces IL-6 production by bone marrow stroma from multiple myeloma patients [abstract].', 'volume': '88', 'author': 'Savage', 'year': '1996', 'journal-title': 'Blood.'} / Blood. / Pamidronate reduces IL-6 production by bone marrow stroma from multiple myeloma patients [abstract]. by Savage (1996)

Dates

Type	When
Created	5 years, 10 months ago (Oct. 13, 2019, 12:01 p.m.)
Deposited	1 year, 11 months ago (Sept. 21, 2023, 11:58 a.m.)
Indexed	2 weeks, 2 days ago (Aug. 21, 2025, 12:53 p.m.)
Issued	25 years, 1 month ago (July 15, 2000)
Published	25 years, 1 month ago (July 15, 2000)
Published Print	25 years, 1 month ago (July 15, 2000)

Funders 0

None

BibTeX

@article{Kunzmann_2000, title={Stimulation of γδ T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma}, volume={96}, ISSN={0006-4971}, url={http://dx.doi.org/10.1182/blood.v96.2.384.013k07_384_392}, DOI={10.1182/blood.v96.2.384.013k07_384_392}, number={2}, journal={Blood}, publisher={American Society of Hematology}, author={Kunzmann, Volker and Bauer, Eva and Feurle, Juliane and Tony, Florian Weißinger, Hans-Peter and Wilhelm, Martin}, year={2000}, month=jul, pages={384–392} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        8,
        21
      ]
    ],
    "date-time": "2025-08-21T16:53:15Z",
    "timestamp": 1755795195396
  },
  "reference-count": 44,
  "publisher": "American Society of Hematology",
  "issue": "2",
  "content-domain": {
    "domain": [
      "ashpublications.org"
    ],
    "crossmark-restriction": true
  },
  "published-print": {
    "date-parts": [
      [
        2000,
        7,
        15
      ]
    ]
  },
  "abstract": "<jats:p>Bisphosphonates are well-known inhibitors of osteoclastic bone resorption, but recent clinical reports support the possibility of direct or indirect antitumor effects by these compounds. Because bisphosphonates share structural homologies with recently identified \u03b3\u03b4 T-cell ligands, we examined the stimulatory capacity of bisphosphonates to \u03b3\u03b4 T cells and determined whether \u03b3\u03b4 T-cell stimulation by bisphosphonates could be exploited to generate antiplasma cell activity in multiple myeloma (MM). All tested aminobisphosphonates (alendronate, ibandronate, and pamidronate) induced significant expansion of \u03b3\u03b4 T cells (V\u03b39V\u03b42 subset) in peripheral blood mononuclear cell cultures of healthy donors at clinically relevant concentrations (half-maximal activity, 0.9-4 \u03bcmol/L). The proliferative response of \u03b3\u03b4 T cells to aminobisphosphonates was IL-2 dependent, whereas activation of \u03b3\u03b4 T cells (up-regulation of CD25 and CD69) occurred in the absence of exogenous cytokines. Pamidronate-activated \u03b3\u03b4 T cells produced cytokines (ie, interferon [IFN]-\u03b3) and exhibited specific cytotoxicity against lymphoma (Daudi) and myeloma cell lines (RPMI 8226, U266). Pamidronate-treated bone marrow (BM) cultures of 24 patients with MM showed significantly reduced plasma cell survival compared with untreated cultures, especially in cultures in which activation of BM-\u03b3\u03b4\u2009T cells was evident (14 of 24 patients with MM). \u03b3\u03b4 T-cell depletion from BM cultures completely abrogated the cytoreductive effect on myeloma cells in 2 of 3 tested patients with MM. These results show that aminobisphosphonates stimulating \u03b3\u03b4 T cells have pronounced effects on the immune system, which might contribute to the antitumor effects of these drugs.</jats:p>",
  "DOI": "10.1182/blood.v96.2.384.013k07_384_392",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2019,
        10,
        13
      ]
    ],
    "date-time": "2019-10-13T16:01:46Z",
    "timestamp": 1570982506000
  },
  "page": "384-392",
  "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000",
  "source": "Crossref",
  "is-referenced-by-count": 143,
  "title": "Stimulation of \u03b3\u03b4 T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma",
  "prefix": "10.1182",
  "volume": "96",
  "author": [
    {
      "given": "Volker",
      "family": "Kunzmann",
      "sequence": "first",
      "affiliation": [
        {
          "name": "From the Medizinische Poliklinik Wuerzburg, Julius\u2013Maximilians Universita\u0308t Wuerzburg, Wuerzburg, Germany."
        }
      ]
    },
    {
      "given": "Eva",
      "family": "Bauer",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Medizinische Poliklinik Wuerzburg, Julius\u2013Maximilians Universita\u0308t Wuerzburg, Wuerzburg, Germany."
        }
      ]
    },
    {
      "given": "Juliane",
      "family": "Feurle",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Medizinische Poliklinik Wuerzburg, Julius\u2013Maximilians Universita\u0308t Wuerzburg, Wuerzburg, Germany."
        }
      ]
    },
    {
      "given": "Florian Wei\u00dfinger, Hans-Peter",
      "family": "Tony",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Medizinische Poliklinik Wuerzburg, Julius\u2013Maximilians Universita\u0308t Wuerzburg, Wuerzburg, Germany."
        }
      ]
    },
    {
      "given": "Martin",
      "family": "Wilhelm",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Medizinische Poliklinik Wuerzburg, Julius\u2013Maximilians Universita\u0308t Wuerzburg, Wuerzburg, Germany."
        }
      ]
    }
  ],
  "member": "234",
  "reference": [
    {
      "key": "2019112005393004600_B1",
      "doi-asserted-by": "crossref",
      "first-page": "488",
      "DOI": "10.1056/NEJM199602223340802",
      "article-title": "Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma: Myeloma Aredia Study Group.",
      "volume": "334",
      "author": "Berenson",
      "year": "1996",
      "journal-title": "N Engl J Med."
    },
    {
      "key": "2019112005393004600_B2",
      "doi-asserted-by": "crossref",
      "first-page": "317",
      "DOI": "10.1046/j.1365-2141.1998.00567.x",
      "article-title": "A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma: MRC Working Party on Leukaemia in Adults.",
      "volume": "100",
      "author": "McCloskey",
      "year": "1998",
      "journal-title": "Br J Haematol."
    },
    {
      "key": "2019112005393004600_B3",
      "doi-asserted-by": "crossref",
      "first-page": "2692",
      "DOI": "10.1172/JCI118722",
      "article-title": "Bisphosphonates: mechanisms of action.",
      "volume": "97",
      "author": "Rodan",
      "year": "1996",
      "journal-title": "J Clin Invest."
    },
    {
      "key": "2019112005393004600_B4",
      "doi-asserted-by": "crossref",
      "first-page": "593",
      "DOI": "10.1200/JCO.1998.16.2.593",
      "article-title": "Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events: Myeloma Aredia Study Group.",
      "volume": "16",
      "author": "Berenson",
      "year": "1998",
      "journal-title": "J Clin Oncol."
    },
    {
      "key": "2019112005393004600_B5",
      "doi-asserted-by": "crossref",
      "first-page": "530",
      "DOI": "10.1046/j.1365-2141.1998.00976.x",
      "article-title": "Antimyeloma activity of pamidronate in vivo.",
      "volume": "103",
      "author": "Dhodapkar",
      "year": "1998",
      "journal-title": "Br J Haematol."
    },
    {
      "key": "2019112005393004600_B6",
      "first-page": "3551",
      "article-title": "Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.",
      "volume": "55",
      "author": "Sasaki",
      "year": "1995",
      "journal-title": "Cancer Res."
    },
    {
      "key": "2019112005393004600_B7",
      "doi-asserted-by": "crossref",
      "first-page": "1787",
      "DOI": "10.1182/blood.V82.6.1787.1787",
      "article-title": "Rapid generation of antiplasma cell activity in the bone marrow of myeloma patients by CD3-activated T cells.",
      "volume": "82",
      "author": "Massaia",
      "year": "1993",
      "journal-title": "Blood."
    },
    {
      "key": "2019112005393004600_B8",
      "first-page": "72",
      "article-title": "Tumor-directed cytotoxicity in multiple myeloma\u2014the basis for an experimental treatment approach with interleukin 2.",
      "volume": "2",
      "author": "Peest",
      "year": "1995",
      "journal-title": "Stem Cells."
    },
    {
      "key": "2019112005393004600_B9",
      "doi-asserted-by": "crossref",
      "first-page": "1016",
      "DOI": "10.1016/S0140-6736(95)90757-2",
      "article-title": "Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor.",
      "volume": "345",
      "author": "Kwak",
      "year": "1995",
      "journal-title": "Lancet."
    },
    {
      "key": "2019112005393004600_B10",
      "doi-asserted-by": "crossref",
      "first-page": "637",
      "DOI": "10.1146/annurev.iy.11.040193.003225",
      "article-title": "Gamma/delta cells.",
      "volume": "11",
      "author": "Haas",
      "year": "1993",
      "journal-title": "Annu Rev Immunol."
    },
    {
      "key": "2019112005393004600_B11",
      "doi-asserted-by": "crossref",
      "first-page": "1269",
      "DOI": "10.1126/science.1978758",
      "article-title": "Recognition by human V\u03b39/V\u03b42 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells.",
      "volume": "250",
      "author": "Fisch",
      "year": "1990",
      "journal-title": "Science."
    },
    {
      "key": "2019112005393004600_B12",
      "doi-asserted-by": "crossref",
      "first-page": "998",
      "DOI": "10.4049/jimmunol.154.3.998",
      "article-title": "V\u03b32V\u03b42 TCR-dependent recognition of nonpeptide antigens and Daudi cells analyzed by TCR gene transfer.",
      "volume": "154",
      "author": "Bukowski",
      "year": "1995",
      "journal-title": "J Immunol."
    },
    {
      "key": "2019112005393004600_B13",
      "doi-asserted-by": "crossref",
      "first-page": "155",
      "DOI": "10.1038/375155a0",
      "article-title": "Natural and synthetic nonpeptide antigens recognized by human \u03b3/\u03b4 T cells.",
      "volume": "375",
      "author": "Tanaka",
      "year": "1995",
      "journal-title": "Nature."
    },
    {
      "key": "2019112005393004600_B14",
      "doi-asserted-by": "crossref",
      "first-page": "267",
      "DOI": "10.1126/science.8146660",
      "article-title": "Stimulation of human \u03b3\u03b4 T cells by nonpeptidic mycobacterial ligands.",
      "volume": "264",
      "author": "Constant",
      "year": "1994",
      "journal-title": "Science."
    },
    {
      "key": "2019112005393004600_B15",
      "doi-asserted-by": "crossref",
      "first-page": "2052",
      "DOI": "10.1002/eji.1830250737",
      "article-title": "Human V\u03b39-V\u03b42 cells are stimulated in a cross-reactive fashion by a variety of phosphorylated metabolites.",
      "volume": "25",
      "author": "Burk",
      "year": "1995",
      "journal-title": "Eur J Immunol."
    },
    {
      "key": "2019112005393004600_B16",
      "doi-asserted-by": "crossref",
      "first-page": "8175",
      "DOI": "10.1073/pnas.91.17.8175",
      "article-title": "Nonpeptide ligands for human \u03b3\u03b4 T cells.",
      "volume": "91",
      "author": "Tanaka",
      "year": "1994",
      "journal-title": "Proc Natl Acad Sci U S A."
    },
    {
      "key": "2019112005393004600_B17",
      "doi-asserted-by": "crossref",
      "first-page": "22",
      "DOI": "10.1016/S0167-5699(97)80010-2",
      "article-title": "Sentinel function of broadly reactive human \u03b3\u03b4 T cells.",
      "volume": "18",
      "author": "De Libero",
      "year": "1997",
      "journal-title": "Immunol Today."
    },
    {
      "key": "2019112005393004600_B18",
      "doi-asserted-by": "crossref",
      "first-page": "737",
      "DOI": "10.1056/NEJM199903043400914",
      "article-title": "\u03b3/\u03b4 T-cell stimulation by pamidronate [letter].",
      "volume": "340",
      "author": "Kunzmann",
      "year": "1999",
      "journal-title": "N Engl J Med."
    },
    {
      "key": "2019112005393004600_B19",
      "doi-asserted-by": "crossref",
      "first-page": "155",
      "DOI": "10.1038/375155a0",
      "article-title": "Natural and synthetic nonpeptide antigens recognized by human \u03b3\u03b4 T cells.",
      "volume": "375",
      "author": "Tanaka",
      "year": "1995",
      "journal-title": "Nature."
    },
    {
      "key": "2019112005393004600_B20",
      "doi-asserted-by": "crossref",
      "first-page": "788",
      "DOI": "10.1093/jnci/84.10.788",
      "article-title": "Pharmacokinetics of pamidronate in patients with bone metastases.",
      "volume": "84",
      "author": "Leyvraz",
      "year": "1992",
      "journal-title": "J Natl Cancer Inst."
    },
    {
      "key": "2019112005393004600_B21",
      "doi-asserted-by": "crossref",
      "first-page": "2095",
      "DOI": "10.1172/JCI115539",
      "article-title": "Bisphosphonate action: alendronate localization in rat bone and effects on osteoclast ultrastructure.",
      "volume": "88",
      "author": "Sato",
      "year": "1991",
      "journal-title": "J Clin Invest."
    },
    {
      "key": "2019112005393004600_B22",
      "doi-asserted-by": "crossref",
      "first-page": "952",
      "DOI": "10.1002/eji.1830270422",
      "article-title": "Comparative analysis of \u03b1\u03b2 and \u03b3\u03b4 T cell activation by Mycobacterium tuberculosis and isopentenyl pyrophosphate.",
      "volume": "27",
      "author": "Wesch",
      "year": "1997",
      "journal-title": "Eur J Immunol."
    },
    {
      "key": "2019112005393004600_B23",
      "doi-asserted-by": "crossref",
      "first-page": "286",
      "DOI": "10.4049/jimmunol.161.1.286",
      "article-title": "Crucial role of TCR \u03b3 chain junctional region in prenyl pyrophosphate antigen recognition by \u03b3\u03b4 T cells.",
      "volume": "161",
      "author": "Bukowski",
      "year": "1998",
      "journal-title": "J Immunol."
    },
    {
      "key": "2019112005393004600_B24",
      "doi-asserted-by": "crossref",
      "first-page": "581",
      "DOI": "10.1359/jbmr.1998.13.4.581",
      "article-title": "Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.",
      "volume": "13",
      "author": "Luckman",
      "year": "1998",
      "journal-title": "J Bone Miner Res."
    },
    {
      "key": "2019112005393004600_B25",
      "doi-asserted-by": "crossref",
      "first-page": "133",
      "DOI": "10.1073/pnas.96.1.133",
      "article-title": "Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro.",
      "volume": "96",
      "author": "Fisher",
      "year": "1999",
      "journal-title": "Proc Natl Acad Sci U S A."
    },
    {
      "key": "2019112005393004600_B26",
      "doi-asserted-by": "crossref",
      "first-page": "1358",
      "DOI": "10.1359/jbmr.1997.12.9.1358",
      "article-title": "Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5\u2032-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro.",
      "volume": "12",
      "author": "Frith",
      "year": "1997",
      "journal-title": "J Bone Miner Res."
    },
    {
      "key": "2019112005393004600_B27",
      "doi-asserted-by": "crossref",
      "first-page": "133",
      "DOI": "10.1016/8756-3282(95)00448-3",
      "article-title": "Interleukin-6 and tumor necrosis factor \u03b1 levels after bisphosphonates treatment in vitro and in patients with malignancy.",
      "volume": "18",
      "author": "Sauty",
      "year": "1996",
      "journal-title": "Bone."
    },
    {
      "key": "2019112005393004600_B28",
      "doi-asserted-by": "crossref",
      "first-page": "386",
      "DOI": "10.1007/s002239900353",
      "article-title": "An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates.",
      "volume": "61",
      "author": "Thiebaud",
      "year": "1997",
      "journal-title": "Calcif Tissue Int."
    },
    {
      "key": "2019112005393004600_B29",
      "first-page": "446a",
      "article-title": "Effects of the bisphosphonates pamidronate, clodronate and ibandronate on CD69, an early T-lymphocyte activation marker [abstract].",
      "volume": "17",
      "author": "Pecherstorfer",
      "year": "1998",
      "journal-title": "Proc ASCO."
    },
    {
      "key": "2019112005393004600_B30",
      "doi-asserted-by": "crossref",
      "first-page": "91",
      "DOI": "10.1084/jem.185.1.91",
      "article-title": "Functional inactivation in the whole population of human V\u03b39/V\u03b42 T lymphocytes induced by a nonpeptidic antagonist.",
      "volume": "185",
      "author": "Burk",
      "year": "1997",
      "journal-title": "J Exp Med."
    },
    {
      "key": "2019112005393004600_B31",
      "doi-asserted-by": "crossref",
      "first-page": "1557",
      "DOI": "10.1084/jem.169.5.1557",
      "article-title": "Cytotoxic T lymphocytes specific for self-tumor immunoglobulin express T cell receptor delta chain.",
      "volume": "169",
      "author": "Wright",
      "year": "1989",
      "journal-title": "J Exp Med."
    },
    {
      "key": "2019112005393004600_B32",
      "first-page": "129",
      "article-title": "Human CD3 \u03b3\u03b4+ activated lymphocytes exhibit killer activity in vitro against autologous leukemic cells.",
      "volume": "31",
      "author": "Bensussan",
      "year": "1989",
      "journal-title": "Nouv Rev Fr Hematol."
    },
    {
      "key": "2019112005393004600_B33",
      "first-page": "863",
      "article-title": "Potential antileukemic effect of \u03b3\u03b4 T cells in acute lymphoblastic leukemia.",
      "volume": "9",
      "author": "Duval",
      "year": "1995",
      "journal-title": "Leukemia."
    },
    {
      "key": "2019112005393004600_B34",
      "doi-asserted-by": "crossref",
      "first-page": "503",
      "DOI": "10.1089/scd.1.1996.5.503",
      "article-title": "Increased frequency of TCR \u03b3\u03b4+ T cells in disease-free survivors following T cell-depleted, partially mismatched, related donor bone marrow transplantation for leukemia.",
      "volume": "5",
      "author": "Lamb",
      "year": "1996",
      "journal-title": "J Hematother."
    },
    {
      "key": "2019112005393004600_B35",
      "doi-asserted-by": "crossref",
      "first-page": "625",
      "DOI": "10.1111/j.1365-2141.1995.tb05594.x",
      "article-title": "CD3-induced T-cell activation in the bone marrow of myeloma patients: major role of CD4+ cells.",
      "volume": "90",
      "author": "Bianchi",
      "year": "1995",
      "journal-title": "Br J Haematol."
    },
    {
      "key": "2019112005393004600_B36",
      "doi-asserted-by": "crossref",
      "first-page": "1078",
      "DOI": "10.1056/NEJM199110103251506",
      "article-title": "A subcutaneous delta-positive T-cell lymphoma that produces interferon gamma.",
      "volume": "325",
      "author": "Burg",
      "year": "1991",
      "journal-title": "N Engl J Med."
    },
    {
      "key": "2019112005393004600_B37",
      "doi-asserted-by": "crossref",
      "first-page": "2999",
      "DOI": "10.1002/eji.1830211215",
      "article-title": "Functionally distinct subsets of human \u03b3/\u03b4 T cells.",
      "volume": "21",
      "author": "Morita",
      "year": "1991",
      "journal-title": "Eur J Immunol."
    },
    {
      "key": "2019112005393004600_B38",
      "doi-asserted-by": "crossref",
      "first-page": "3076",
      "DOI": "10.1182/blood.V81.11.3076.3076",
      "article-title": "\u03b3-Interferon in multiple myeloma: inhibition of interleukin-6 (IL-6)-dependent myeloma cell growth and downregulation of IL-6-receptor expression in vitro.",
      "volume": "81",
      "author": "Portier",
      "year": "1993",
      "journal-title": "Blood."
    },
    {
      "key": "2019112005393004600_B39",
      "doi-asserted-by": "crossref",
      "first-page": "2914",
      "DOI": "10.1182/blood.V92.8.2914.420k14_2914_2923",
      "article-title": "Fas/APO-1 (CD95)-mediated apoptosis is activated by interferon-\u03b3 and interferon-\u03b1 in interleukin-6 (IL-6)-dependent and IL-6-independent multiple myeloma cell lines.",
      "volume": "92",
      "author": "Spets",
      "year": "1998",
      "journal-title": "Blood."
    },
    {
      "key": "2019112005393004600_B40",
      "doi-asserted-by": "crossref",
      "first-page": "665",
      "DOI": "10.1046/j.1365-2141.1997.2713086.x",
      "article-title": "Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.",
      "volume": "98",
      "author": "Shipman",
      "year": "1997",
      "journal-title": "Br J Haematol."
    },
    {
      "key": "2019112005393004600_B41",
      "doi-asserted-by": "crossref",
      "first-page": "220",
      "DOI": "10.1038/sj.leu.2400892",
      "article-title": "In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates.",
      "volume": "12",
      "author": "Aparicio",
      "year": "1998",
      "journal-title": "Leukemia."
    },
    {
      "key": "2019112005393004600_B42",
      "first-page": "5294",
      "article-title": "The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway.",
      "volume": "58",
      "author": "Shipman",
      "year": "1998",
      "journal-title": "Cancer Res."
    },
    {
      "key": "2019112005393004600_B43",
      "doi-asserted-by": "crossref",
      "first-page": "38",
      "DOI": "10.1080/030097498441155",
      "article-title": "Bisphosphonates inhibit IL-6 production by human osteoblast-like cells.",
      "volume": "27",
      "author": "Giuliani",
      "year": "1998",
      "journal-title": "Scand J Rheumatol."
    },
    {
      "key": "2019112005393004600_B44",
      "first-page": "105a",
      "article-title": "Pamidronate reduces IL-6 production by bone marrow stroma from multiple myeloma patients [abstract].",
      "volume": "88",
      "author": "Savage",
      "year": "1996",
      "journal-title": "Blood."
    }
  ],
  "container-title": "Blood",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://ashpublications.org/blood/article/96/2/384/52725/Stimulation-of-%CE%B3%CE%B4-T-cells-by-aminobisphosphonates",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "syndication"
    },
    {
      "URL": "https://ashpublications.org/blood/article/96/2/384/52725/Stimulation-of-%CE%B3%CE%B4-T-cells-by-aminobisphosphonates",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2023,
        9,
        21
      ]
    ],
    "date-time": "2023-09-21T15:58:07Z",
    "timestamp": 1695311887000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://ashpublications.org/blood/article/96/2/384/52725/Stimulation-of-%CE%B3%CE%B4-T-cells-by-aminobisphosphonates"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2000,
        7,
        15
      ]
    ]
  },
  "references-count": 44,
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2000,
          7,
          15
        ]
      ]
    }
  },
  "URL": "http://dx.doi.org/10.1182/blood.V96.2.384.013k07_384_392",
  "relation": {},
  "ISSN": [
    "1528-0020",
    "0006-4971"
  ],
  "subject": [],
  "published": {
    "date-parts": [
      [
        2000,
        7,
        15
      ]
    ]
  }
}